Sofokast 400mg Tablet is a direct-acting antiviral medication that inhibits the RNA polymerase enzyme necessary for HCV replication.
When combined with other antiviral drugs, it leads to high cure rates, improved treatment outcomes, and shorter treatment durations.
Interaction with other drugs:
Inform the doctor about all medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products.
Certain medications may interact with Sofokast 400mg Tablet, reducing effectiveness or causing undesirable side effects.
Storage:
Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
Keep away from moisture, heat, and light.
Do not freeze.
Keep away from children and pets.
How to consume:
Sofokast 400mg Tablet is typically prescribed with other antiviral medications.
Take orally once a day, with or without food.
Complete the full course of treatment as prescribed to ensure the best chance of achieving a sustained virologic response (SVR) and curing the HCV infection.
Safety Advices:
Pregnancy: The safety of Sofokast 400mg Tablet use during pregnancy has not been established.
Breastfeeding: Limited data are available on the safety of Sofokast 400mg Tablet during breastfeeding.
Lungs: Consult with your healthcare provider if you have a pre-existing lung condition.
Liver: If you have a liver condition, consult your healthcare provider for personalized advice.
Alcohol: Avoid consuming alcohol while taking Sofokast 400mg Tablet.
Driving: Avoid driving or operating heavy machinery after using Sofokast 400mg Tablet if you experience side effects such as dizziness, drowsiness, or fatigue.
Side Effects:
Serious: Allergic reactions that affect skin and breathing, hepatitis B infection reactivation, bradycardia (slow heartbeat).
Before starting treatment, inform your healthcare provider if you have a history of hepatitis B.
Liver function and HBV DNA levels will be closely monitored during treatment.
Be aware of the risk of serious bradycardia when Sofokast 400mg Tablet is combined with Amiodarone.
Report any signs of allergic reactions immediately.
Pregnant and breastfeeding individuals should discuss the potential risks and benefits with their healthcare provider.
FAQs:
Can Sofokast 400mg Tablet be used as a single therapy for hepatitis C?
No, Sofokast 400mg Tablet is not recommended as a monotherapy for hepatitis C. It is typically used in combination with other antiviral medications.
Can Sofokast 400mg Tablet prevent hepatitis C transmission?
Sofokast 400mg Tablet primarily treats individuals already infected with hepatitis C. While it can cure the infection and reduce the viral load, it does not provide direct protection against acquiring hepatitis C or prevent transmission to others.
Can Sofokast 400mg Tablet be used in patients with liver cirrhosis?
Yes, Sofokast 400mg Tablet can be used in patients with liver cirrhosis. However, careful monitoring and individualized treatment plans may be required for patients with advanced liver disease.
Can Sofokast 400mg Tablet cause weight gain?
Weight gain is not a commonly reported side effect of Sofokast 400mg Tablet.
Can Sofokast 400mg Tablet be used in elderly patients?
Yes, Sofokast 400mg Tablet can be used in elderly patients. However, elderly patients may have a higher likelihood of comorbidities and may be taking multiple medications, which can increase the risk of drug interactions.
What are the side effects of Sofokast 400mg Tablet?
Common side effects may include fatigue, headache, nausea, insomnia, diarrhea, itching, decreased appetite, and rash or skin reactions. Serious side effects are rare, including hepatitis B reactivation in co-infected individuals, serious bradycardia when combined with Amiodarone, and allergic reactions.
Can Sofokast 400mg Tablet be used in patients with HIV?
Yes, Sofokast 400mg Tablet can be used in patients who are co-infected with both hepatitis C virus (HCV) and HIV. However, the choice may depend on the specific antiretroviral therapy used to treat HIV.
Fact Box:
Molecule name: Sofosbuvir
Therapeutic class: Antiviral Agent
Pharmacological class: Nucleotide analog inhibitor
